The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: Toward a mutation-specific risk stratification

Lia Crotti, Carla Spazzolini, Peter J. Schwartz, Wataru Shimizu, Isabelle Denjoy, Eric Schulze-Bahr, Elena V. Zaklyazminskaya, Heikki Swan, Michael J. Ackerman, Arthur J. Moss, Arthur A M Wilde, Minoru Horie, Paul A. Brink, Roberto Insolia, Gaetano M. De Ferrari, Gabriele Crimi

Research output: Contribution to journalArticle

Abstract

BACKGROUND - The impressive clinical heterogeneity of the long-QT syndrome (LQTS) remains partially unexplained. In a South African (SA) founder population, we identified a common LQTS type 1 (LQT1)-causing mutation (KCNQ1-A341V) associated with high clinical severity. We tested whether the arrhythmic risk was caused directly by A341V or by its presence in the specific ethnic setting of the SA families. METHODS AND RESULTS - Seventy-eight patients, all with a single KCNQ1-A341V mutation, from 21 families and 8 countries were compared with 166 SA patients with A341V and with 205 non-A341V LQT1 patients. In the 2 A341V populations (SA and non-SA), the probability of a first event through 40 years of age was similar (76% and 82%), and the QTc was 484±42 versus 485±45 ms (P=NS). Compared with the 205 non-A341V patients with the same median follow-up (30 versus 32 years), the 244 A341V patients were more likely to have cardiac events (75% versus 24%), were younger at first event (6 versus 11 years), and had a longer QTc (485±43 versus 465±38 ms) (all P

Original languageEnglish
Pages (from-to)2366-2375
Number of pages10
JournalCirculation
Volume116
Issue number21
DOIs
Publication statusPublished - Nov 2007

Keywords

  • Arrhythmia
  • Death, sudden
  • Genetics
  • Long-QT syndrome
  • Risk factors

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: Toward a mutation-specific risk stratification'. Together they form a unique fingerprint.

  • Cite this